Search - tctmd.com

Displaying 861 - 880 of 901

Sort: Relevancy | Date

News Daily News

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

Michael O'Riordan

March 09, 2016

News Daily News

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

Michael O'Riordan

March 09, 2016

News Daily News

备受争议的 LIGHT 试验现已发表，但未能证实 Contrave 的心血管风险

Michael O'Riordan

March 08, 2016

News Daily News

El Controvertido Ensayo LIGHT Ahora Publicado No Arroja Luz sobre los Riesgos CV de Contrave

Michael O'Riordan

March 08, 2016

News Daily News

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Michael O'Riordan

March 08, 2016

News Daily News

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

Michael O'Riordan

March 01, 2016

News Daily News

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

Michael O'Riordan

March 01, 2016

News Daily News

双倍剂量的氯吡格雷可以解决“吸烟者悖论”：GRAVITAS 分析

Michael O'Riordan

February 28, 2016

News Daily News

Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel

Michael O'Riordan

February 28, 2016

News Daily News

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

Michael O'Riordan

February 28, 2016

News Daily News

大环内酯类抗生素：队列研究显示其与室性心律失常的风险及死亡率增加无关

Michael O'Riordan

February 25, 2016

News Daily News

Macrolide Antibiotics: No Link With Increased Risk of Ventricular Arrhythmia, Mortality in Cohort Study

Michael O'Riordan

February 25, 2016

News Daily News

Antibióticos Macrólidos: No Acarrean un Mayor Riesgo de Arritmia Ventricular Ni de Mortalidad según un Estudio de Cohorte

Michael O'Riordan

February 25, 2016

News Daily News

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Michael O'Riordan

February 23, 2016

News Daily News

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Michael O'Riordan

February 23, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Conference News ISET 2016

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

Michael O'Riordan

February 15, 2016

News Conference News ISET 2016

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

Michael O'Riordan

February 09, 2016

News Conference News ISET 2016

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Michael O'Riordan

February 08, 2016

News Daily News

Un Centro Experimenta un Descenso en el Volumen y Reembolsos PCI Tras Implementar CUA

Michael O'Riordan

February 04, 2016

Advertisement

Will FDA’s Settlement With Amarin Weaken Agency Oversight of Off-Label Promotion?

FDA 与阿玛琳之间的和解是否会减弱该局对标签外用途推广的监督？

备受争议的 LIGHT 试验现已发表，但未能证实 Contrave 的心血管风险

El Controvertido Ensayo LIGHT Ahora Publicado No Arroja Luz sobre los Riesgos CV de Contrave

Controversial LIGHT Trial Now Published but Fails to Illuminate CV Risks of Contrave

Elevated LDL Cholesterol in Mom, Increased LDL Cholesterol in Adult Offspring, Irrespective of Genetics

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

双倍剂量的氯吡格雷可以解决“吸烟者悖论”：GRAVITAS 分析

Análisis del Ensayo GRAVITAS: La ‘Paradoja del Fumador’ Desaparece con Dosis Dobles de Clopidogrel

‘Smoker’s Paradox’ Eliminated With Double Dose of Clopidogrel: GRAVITAS Analysis

大环内酯类抗生素：队列研究显示其与室性心律失常的风险及死亡率增加无关

Macrolide Antibiotics: No Link With Increased Risk of Ventricular Arrhythmia, Mortality in Cohort Study

Antibióticos Macrólidos: No Acarrean un Mayor Riesgo de Arritmia Ventricular Ni de Mortalidad según un Estudio de Cohorte

生物可吸收支架导致装置血栓风险增加，但一些人士表示风险可得到抑制

Mayor Riesgo de Trombsosis del Dispositivo con Andamiajes Bioabsorbibles Aunque Algunos Riesgos Pueden Mitigarse

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

Tumors, Bad Backs, and Cataracts: Interventional Physicians Face a Lifetime of Risk

‘Encouraging’ Early Findings With Embolic Protection in TEVAR, Suggests Small Pilot Study

Un Centro Experimenta un Descenso en el Volumen y Reembolsos PCI Tras Implementar CUA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content